EFFECTS OF ATORVASTATIN AND MELATONIN ON GLYCEMIC CONTROL AND LIPID PROFILE IN TYPE 2 DIABETIC PATIENTS
Background: Dyslipidemia is a modifiable cardiovascular disease risk factor that remains largely uncontrolled in patients with type 2 diabetes mellitus. Administration of melatonin may improve tissue responses to insulin and increase the efficacy of drugs which act through this pathway like Sulfonyl...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Al-Nahrain University/College of medicine
2016-03-01
|
| Serija: | The Iraqi Journal of Medical Sciences |
| Teme: | |
| Online dostop: | https://iraqijms.com/index.php/jms/article/view/116 |
| Oznake: |
Brez oznak, prvi označite!
|